RNF43 Inactivation Enhances the B‐RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer CellsShih‐Han Hsu(National Health Research Institutes), Wen‐Chun Hung(National Yang Ming Chiao Tung University)Advanced ScienceJanuary 15, 202410.1002/advs.202304820Cited by 7SaveCiteExport RISWatch citationsRelated PapersForetinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer<i>in vivo</i>by decreasing VEGFR-2/3 and TIE-2 signaling|Oncotarget|2015|62Lysine demethylase 2A expression in cancer-associated fibroblasts promotes breast tumour growth|British Journal of Cancer|2020|26Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells|Oncology Reports|2012|12